Melanoma-specific clinical outcomes of inpatient immune checkpoint blockade treatment Journal Article


Authors: Loo, K.; Kalvin, H. L.; Panageas, K. S.; Park, V.; Postow, M. A.
Article Title: Melanoma-specific clinical outcomes of inpatient immune checkpoint blockade treatment
Abstract: BACKGROUND: Little is known about patient outcomes with advanced melanoma following inpatient initiation or continuation of immune checkpoint blockade (ICB). METHODS AND RESULTS: We conducted a single institution retrospective case series of advanced melanoma patients who initiated ICB as an inpatient (initial inpatient cohort, n = 9), or continued ICB as an inpatient after previously starting as an outpatient (outpatient then inpatient cohort, n = 5). One patient had a partial response to ICB initiated as an inpatient, but ultimately died of melanoma after 13.5 months. Median overall survival for initial inpatient cohort was 1.0 month (95% CI: 0.2-11.2), and 1.4 months (95% CI: 0.4-58.0) for the outpatient then inpatient cohort. Three patients were alive >6 months after inpatient ICB administration. CONCLUSION: Despite overall poor outcomes, some patients may benefit from inpatient ICB. This study provides additional information for clinicians to appropriately counsel patients on expectations following inpatient ICB. © The Author(s) 2022. Published by Oxford University Press.
Keywords: retrospective studies; melanoma; retrospective study; immunotherapy; hospital patient; inpatients; humans; human; immune checkpoint inhibitors; inpatient treatment
Journal Title: The Oncologist
Volume: 27
Issue: 9
ISSN: 1083-7159
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: e755
End Page: e758
Language: English
DOI: 10.1093/oncolo/oyac121
PUBMED: 35766876
PROVIDER: scopus
PMCID: PMC9438908
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    362 Postow
  2. Vivian Park
    13 Park
  3. Katherine S Panageas
    512 Panageas
  4. Kimberly Leticia Loo
    6 Loo
  5. Hannah Kalvin
    30 Kalvin